- Investing Ideas
- Finnish Healthcare Undervalued over 20% based on DCF
Finnish Healthcare Undervalued over 20% based on DCF
Results
2
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
2 companies
Nexstim
Market Cap: €77.1m
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
NXTMH
€9.55
7D
-1.7%
1Y
-29.3%
Biohit Oyj
Market Cap: €39.7m
A biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.
New
BIOBV
€2.61
7D
-1.5%
1Y
-8.4%